Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

09. Juni 2011 08:30 ET | Quelle: Harbor BioSciences, Inc.

Harbor BioSciences and CIPI Sign Umbrella Distribution Agreement

SAN DIEGO, June 9, 2011 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (OTCBB:HRBR) today announced that it has signed an umbrella generic drugs distribution agreement with China Institute of...
28. Februar 2011 08:30 ET | Quelle: Harbor BioSciences, Inc.

Harbor BioSciences Preclinical Study of Apoptone(R) in Breast Cancer Published in the International Journal of Breast Cancer

SAN DIEGO, Feb. 28, 2011 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (OTCBB:HRBR), a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory...
22. Februar 2011 08:30 ET | Quelle: Harbor BioSciences, Inc.

Initial Studies Show Harbor BioSciences' Triolex(R) for Parkinson's Disease Crosses the Blood-Brain Barrier in Mice

SAN DIEGO, Feb. 22, 2011 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (OTCBB:HRBR), which is investigating the use the company's proprietary compound Triolex® as a treatment for Parkinson's...
07. Februar 2011 08:30 ET | Quelle: Harbor BioSciences, Inc.

Harbor BioSciences Wraps Up Phase I/IIa Prostate Cancer Study

SAN DIEGO, Feb. 7, 2011 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (OTCBB:HRBR), a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory...
01. Februar 2011 08:30 ET | Quelle: Harbor BioSciences, Inc.

Harbor BioSciences Discovery of New Anti-Inflammatory Steroids Published in Peer Reviewed Scientific Journal

SAN DIEGO, Feb. 1, 2011 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (OTCBB:HRBR), a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory...
18. Januar 2011 08:30 ET | Quelle: Harbor BioSciences, Inc.

Harbor BioSciences Signs Pharmaceutical Development Agreements With China State Institute of Pharmaceutical Industry (CIPI)

SAN DIEGO, Jan. 18, 2011 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (OTCBB:HRBR), a leader in the development of a proprietary class of adrenal steroid hormones as novel pharmaceuticals, announced...
20. September 2010 08:00 ET | Quelle: Harbor BioSciences, Inc.

Harbor BioSciences Receives Patent for Triolex(R) and Other Compounds

SAN DIEGO, Sept. 20, 2010 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (Nasdaq:HRBR) today announced that the company has received patent No. 7,776,845 from the United States Patent and Trademark...
17. September 2010 17:00 ET | Quelle: Harbor BioSciences, Inc.

Harbor BioSciences Receives NASDAQ Notice of Delisting

SAN DIEGO, Sept. 17, 2010 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (Nasdaq:HRBR) received notification from NASDAQ that it has not complied with NASDAQ Listing Rule 5550(a)(2) and, unless the...
14. September 2010 16:30 ET | Quelle: Harbor BioSciences, Inc.

Harbor BioSciences Apoptone(R) for Prostate Cancer Shows a Partial Overall Response

SAN DIEGO, Sept. 14, 2010 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (Nasdaq:HRBR) a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory...
10. Juni 2010 16:15 ET | Quelle: Harbor BioSciences, Inc.

Harbor BioSciences Announces Closing of $2.06 Million Equity Financing

SAN DIEGO, June 10, 2010 (GLOBE NEWSWIRE) -- Harbor BioSciences, Inc. (Nasdaq:HRBR) announced today that it has closed its previously announced sale of approximately $2.06 million of its common stock...

Nächste Seite